SS&C to Release Second Quarter 2025 Earnings

WINDSOR, Conn.--(BUSINESS WIRE)-- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services and healthcare software and software-enabled services, will announce its financial results for the second quarter ended June 30, 2025 after the close of the market on Wednesday, July 23, 2025. The earnings conference call, scheduled for Wednesday, July 23, 2025 at 5:00 p.m. Eastern Time, will discuss second quarter 2025 results.

Details of the release are as follows:

News Release: To be released on July 23, 2025. The release will be available over BUSINESS WIRE and from SS&C’s website at www.ssctech.com. To receive the press release via email immediately after wire distribution, visit investor.ssctech.com and click on Email Alerts.

Earnings Call: Dial 888-210-4650 (US and Canada) or 646-960-0327 (International) and request the “SS&C Technologies Second Quarter 2025 Earnings Conference Call”; conference ID #4673675.

Webcast: A live webcast of its earnings conference call will be available at the Investor Relations section of SS&C’s website, investor.ssctech.com. A replay will be available after the conclusion of the live webcast.

About SS&C Technologies

SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. More than 22,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.
Follow SS&C on X, LinkedIn, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250707110646/en/

For more information
Brian Schell
Chief Financial Officer
SS&C Technologies
Tel: +1-816-642-0915 | E-mail: [email protected]

Justine Stone
Head of Investor Relations SS&C Technologies
Tel: +1-212-367-4705 | E-mail: [email protected]

Chand Madaka
Investor Relations
SS&C Technologies
Tel: +1-908-845-1259 | E-mail: [email protected]

Source: SS&C

You May Also Be Interested In

• FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation
• Silver Pony Announces OTC Symbol Change to PONIF Following Name Change
• MACH OE, an Open-Ended Aircraft Fund, Announces the First Aircraft Deliveries